Plague is a severe bacterial infection that may cause death.
Bubonic plague; Pneumonic plague; Septicemic plague
Plague is caused by the bacteria Yersinia pestis. Rodents, such as rats, carry the disease. It is spread by fleas.
People can get plague when they are bitten by a flea that carries the plague bacteria from an infected rodent. In rare cases, people get the disease when handling an infected animal.
Plague lung infection is called pneumonic plague. It can be spread from person to person. When someone with pneumonic plague coughs, tiny droplets carrying the bacteria move through the air. Anyone who breathes in these particles may catch the disease. An epidemic can be started this way.
In the Middle Ages in Europe, massive plague epidemics killed millions of people. Plague has not been eliminated. It can still be found in Africa, Asia, and South America.
Today, plague is rare in the United States. But it has been known to occur in parts of California, Arizona, Colorado, and New Mexico.
There three most common forms of plague are:
The time between being infected and developing symptoms is typically 2 to 8 days. But the time can be as short as 1 day for pneumonic plague.
Risk factors for plague include a recent flea bite and exposure to rodents, especially rabbits, squirrels, or prairie dogs, or scratches or bites from infected domestic cats.
Bubonic plague symptoms appear suddenly, usually 2 to 5 days after exposure to the bacteria. Symptoms include:
Pneumonic plague symptoms appear suddenly, typically 1 to 4 days after exposure. They include:
Septicemic plague may cause death even before severe symptoms occur. Symptoms can include:
People with the plague need to be treated right away. If treatment is not received within 24 hours of when the first symptoms occur, the risk for death increases.
Antibiotics such as streptomycin, gentamicin, doxycycline, or ciprofloxacin are used to treat plague. Oxygen, intravenous fluids, and respiratory support are usually also needed.
People with pneumonic plague must be kept away from other patients and isolation procedures will be followed in the hospital. People who have had contact with anyone infected by pneumonic plague should be watched carefully and given antibiotics as a preventive measure.
Minoarisoa Rajerison practices in Antananarivo, Madagascar. Rajerison is rated as an Elite expert by MediFind in the treatment of Plague. They are also highly rated in 1 other condition, according to our data. Their top areas of expertise are Plague, Leptospirosis, Rocky Mountain Spotted Fever, and Rickettsialpox.
Voahangy Andrianaivoarimanana practices in Antananarivo, Madagascar. Andrianaivoarimanana is rated as an Elite expert by MediFind in the treatment of Plague. They are also highly rated in 1 other condition, according to our data. Their top areas of expertise are Plague and Tularemia.
Soanandrasana Rahelinirina practices in Antananarivo, Madagascar. Rahelinirina is rated as an Elite expert by MediFind in the treatment of Plague. They are also highly rated in 2 other conditions, according to our data. Their top areas of expertise are Plague, Leptospirosis, and Intestinal Parasitosis.
Without treatment, about 50% of people with bubonic plague die. Almost everyone with septicemic or pneumonic plague dies if not treated right away. Treatment reduces the death rate to 50%.
Contact your provider if you develop plague symptoms after exposure to fleas or rodents. Contact your provider if you live in or have visited an area where plague occurs.
Rat control and watching for the disease in the wild rodent population are the main measures used to control the risk for epidemics. The plague vaccine is no longer used in the United States.
Summary: Plague is a deadly but highly treatable disease caused by the bacterium Y. pestis. Due to the historical development of Y. pestis as a bioweapon by several nation states, it is listed by the US as a potential bioweapon that could be used against US warfighters. Although this bacterium is ecologically established worldwide, it mostly affects impoverished people who live in rural low-resource areas ...
Summary: The primary objective of this trial is to test the hypothesis that ciprofloxacin monotherapy given (orally, intravenously, or combination) for 10 days is non-inferior to an aminoglycoside (given on days 1-3) followed by ciprofloxacin (given on days 4-10) in the treatment of bubonic plague. Secondary objectives are: - to evaluate the level and kinetics of anti-Y. pestis antibodies of patients (bubo...
Published Date: June 20, 2021
Published By: Jatin M. Vyas, MD, PhD, Associate Professor in Medicine, Harvard Medical School; Associate in Medicine, Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, MA. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Mead PS, Nelson CA. Plague and other Yersinia infections. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier; 2020:chap 296.
Mead PS. Plague (Yersinia pestis). In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 9th ed. Philadelphia, PA: Elsevier; 2020:chap 229.